BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 24941234)

  • 1. Which is currently the best strategy for treatment of SFA in-stent restenosis?
    Elens M; Verbist J; Keirse K; Van Den Eynde W; Peeters P
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):477-81. PubMed ID: 24941234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V; Stabile E; Biamino G; Salemme L; Cioppa A; Giugliano G; Tesorio T; Cota L; Popusoi G; Pucciarelli A; Esposito G; Trimarco B; Rubino P
    JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease.
    Lichtenberg MK; Carr JG; Golzar JA
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):518-527. PubMed ID: 28382804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis.
    Beschorner U; Zeller T
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):347-9. PubMed ID: 24755703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role for DCBs in the treatment of ISR.
    Bague N; Nasr B; Chaillou P; Costargent A; Gouailler-Vulcain F; Goueffic Y
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):578-85. PubMed ID: 27102629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
    Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
    J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
    Zeller T; Dake MD; Tepe G; Brechtel K; Noory E; Beschorner U; Kultgen PL; Rastan A
    JACC Cardiovasc Interv; 2013 Mar; 6(3):274-81. PubMed ID: 23517839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoropopliteal in-stent restenosis: current treatment strategies.
    Singh GD; Armstrong EJ; Laird JR
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):325-33. PubMed ID: 24755700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results.
    Stahlhoff S; Donas KP; Torsello G; Osada N; Herten M
    J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of in-stent restenosis in peripheral arteries: are DEBs sufficient as stand-alone treatment for femoro-popliteal in-stent restenosis?
    Franzone A; Stabile E; Carbone A; Scudiero F; Trimarco B; Esposito G
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):335-8. PubMed ID: 24755701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-stent restenosis management: the best is yet to come.
    van den Berg JC
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):508-517. PubMed ID: 28322039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting balloons to treat iliac in-stent restenosis.
    Troisi N; Ercolini L; Peretti E; Ferraresi R; Pitì A; Setti M; Michelagnoli S
    Ann Vasc Surg; 2015 Aug; 29(6):1315.e3-6. PubMed ID: 26028465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.